Literature DB >> 29224058

Systematic assessment and characterization of chronic pain in multiple sclerosis patients.

Diana Ferraro1, Domenico Plantone2, Franca Morselli1, Giulia Dallari3, Anna M Simone1, Francesca Vitetta1, Patrizia Sola1, Guido Primiano4, Viviana Nociti4,5, Matteo Pardini6,7, Massimiliano Mirabella4, Catello Vollono4.   

Abstract

Pain is one of the most disabling clinical symptoms in patients with multiple sclerosis (MS). Several studies have already assessed the prevalence of pain in MS patients, reporting variable results, probably due to methodological differences. The aim of this single-centre cross-sectional study was to define the prevalence and characteristics of chronic pain in a population of MS patients using validated tools, and to analyse these data in relation to demographic and clinical features, including disease duration and disability (EDSS and its single functional system scores). Of 397 enrolled patients, 23 were excluded due to a Beck's Depression Inventory Score > 19. In the remaining 374 patients, the overall prevalence of chronic pain was 52.1%, most frequently affecting the lower limbs (36.9%). Neuropathic pain was the most frequent type of chronic pain (89 patients, overall prevalence of 23.7%) and was associated with a sensory functional system involvement. Pain intensity was significantly higher in patients with neuropathic pain as opposed to patients with non-neuropathic pain. Patients with chronic pain and, in particular, patients with neuropathic pain had significantly higher EDSS scores than those without pain. Only 24% of patients with chronic pain and 33% of patients with neuropathic pain were on a specific long-lasting treatment for pain. The present study supports the routine assessment of neuropathic pain in MS patients, especially in those with a sensory functional system involvement, in order to avoid underdiagnosing and undertreating a potentially disabling condition.

Entities:  

Keywords:  Multiple sclerosis; Neuropathic symptoms; Pain; Pain treatment

Mesh:

Substances:

Year:  2017        PMID: 29224058     DOI: 10.1007/s10072-017-3217-x

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  40 in total

1.  Severity of chronic pain and its relationship to quality of life in multiple sclerosis.

Authors:  Lorraine V Kalia; Paul W O'Connor
Journal:  Mult Scler       Date:  2005-06       Impact factor: 6.312

2.  Depression and chronic pain.

Authors:  Alex Holmes; Nicholas Christelis; Carolyn Arnold
Journal:  Med J Aust       Date:  2013-09-16       Impact factor: 7.738

3.  Mechanisms of pain in multiple sclerosis: a combined clinical and neurophysiological study.

Authors:  Andrea Truini; Francesca Galeotti; Silvia La Cesa; Simone Di Rezze; Antonella Biasiotta; Giulia Di Stefano; Emanuele Tinelli; Enrico Millefiorini; Antonio Gatti; Giorgio Cruccu
Journal:  Pain       Date:  2012-07-11       Impact factor: 6.961

4.  Validation of DN4 as a screening tool for neuropathic pain in painful diabetic polyneuropathy.

Authors:  V Spallone; R Morganti; C D'Amato; C Greco; L Cacciotti; G A Marfia
Journal:  Diabet Med       Date:  2012-05       Impact factor: 4.359

5.  Pain and sensory complaints in multiple sclerosis.

Authors:  A G Beiske; E D Pedersen; B Czujko; K-M Myhr
Journal:  Eur J Neurol       Date:  2004-07       Impact factor: 6.089

Review 6.  An intricate relationship between pain and depression: clinical correlates, coactivation factors and therapeutic targets.

Authors:  Kanwaljit Chopra; Vipin Arora
Journal:  Expert Opin Ther Targets       Date:  2013-12-03       Impact factor: 6.902

7.  The pain experience of a multiple sclerosis population: a descriptive study.

Authors:  P Warnell
Journal:  Axone       Date:  1991-09

8.  Development and validation of the Neuropathic Pain Symptom Inventory.

Authors:  Didier Bouhassira; Nadine Attal; Jacques Fermanian; Haiel Alchaar; Michèle Gautron; Etienne Masquelier; Sylvie Rostaing; Michel Lanteri-Minet; Elisabeth Collin; Jacques Grisart; François Boureau
Journal:  Pain       Date:  2004-04       Impact factor: 6.961

9.  Validation of the Italian version of the Neuropathic Pain Symptom Inventory in peripheral nervous system diseases.

Authors:  Luca Padua; Chiara Briani; Stefano Jann; Eduardo Nobile-Orazio; Costanza Pazzaglia; Alberto Morini; Mauro Mondelli; Palma Ciaramitaro; Guido Cavaletti; Dario Cocito; Raffaella Fazio; Lucio Santoro; Francesca Galeotti; Marinella Carpo; Rosaria Plasmati; Luana Benedetti; Angelo Schenone; Paolo Marchettini; Giorgio Cruccu
Journal:  Neurol Sci       Date:  2009-02-06       Impact factor: 3.307

10.  Chronic pain in multiple sclerosis: prevalence, characteristics, and impact on quality of life in an Australian community cohort.

Authors:  Fary Khan; Julie Pallant
Journal:  J Pain       Date:  2007-05-31       Impact factor: 5.820

View more
  12 in total

1.  [Pain in multiple sclerosis and neuromyelitis optica spectrum disorders].

Authors:  Hannah L Pellkofer; Tania Kümpfel
Journal:  Schmerz       Date:  2021-05-25       Impact factor: 1.107

2.  [Cannabinoids in pain medicine].

Authors:  M Karst
Journal:  Schmerz       Date:  2018-10       Impact factor: 1.107

3.  Combined upper limb and breathing exercise programme for pain management in ambulatory and non-ambulatory multiple sclerosis individuals: part II analyses from feasibility study.

Authors:  Tanja Grubić Kezele; Matea Babić; Tamara Kauzlarić-Živković; Tamara Gulić
Journal:  Neurol Sci       Date:  2019-08-17       Impact factor: 3.307

4.  Italian version of the Starkstein Apathy Scale (SAS-I) and a shortened version (SAS-6) to assess "pure apathy" symptoms: normative study on 392 individuals.

Authors:  Elisabetta Garofalo; Alessandro Iavarone; Sergio Chieffi; Michele Carpinelli Mazzi; Nadia Gamboz; Ferdinando Ivano Ambra; Maria Sannino; Filomena Galeone; Sabrina Esposito; Bruno Ronga; Ciro Rosario Ilardi
Journal:  Neurol Sci       Date:  2020-07-29       Impact factor: 3.307

5.  Exploring the feasibility of a mild and short 4-week combined upper limb and breathing exercise program as a possible home base program to decrease fatigue and improve quality of life in ambulatory and non-ambulatory multiple sclerosis individuals.

Authors:  Tanja Grubić Kezele; Matea Babić; Dinko Štimac
Journal:  Neurol Sci       Date:  2019-01-18       Impact factor: 3.307

6.  Cannabis for Neuropathic Pain in Multiple Sclerosis-High Expectations, Poor Data.

Authors:  Thorsten Rudroff
Journal:  Front Pharmacol       Date:  2019-10-22       Impact factor: 5.810

7.  Effects of hypnosis, cognitive therapy, hypnotic cognitive therapy, and pain education in adults with chronic pain: a randomized clinical trial.

Authors:  Mark P Jensen; Maria Elena Mendoza; Dawn M Ehde; David R Patterson; Ivan R Molton; Tiara M Dillworth; Kevin J Gertz; Joy Chan; Shahin Hakimian; Samuel L Battalio; Marcia A Ciol
Journal:  Pain       Date:  2020-10       Impact factor: 7.926

8.  Pain Characteristics and Associations with Quality of Life in Patients with Multiple Sclerosis in Lithuania.

Authors:  Greta Veličkaitė; Neringa Jucevičiūtė; Renata Balnytė; Ovidijus Laucius; Antanas Vaitkus
Journal:  Medicina (Kaunas)       Date:  2020-11-08       Impact factor: 2.430

9.  Clinical problems of patients with cachexia due to chronic illness: a congress report.

Authors:  Sara Hadzibegovic; Philipp Sikorski; Sophia K Potthoff; Jochen Springer; Alessia Lena; Markus S Anker
Journal:  ESC Heart Fail       Date:  2020-10-04

10.  Strain and sex differences in somatosensation and sociability during experimental autoimmune encephalomyelitis.

Authors:  Katelynn Ondek; Aida Nasirishargh; Jacquelyn R Dayton; Miriam A Nuño; Lillian Cruz-Orengo
Journal:  Brain Behav Immun Health       Date:  2021-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.